These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 38612708)

  • 1. Association between Parkinson's Disease and Cancer: New Findings and Possible Mediators.
    Surguchov A; Surguchev AA
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers.
    Sugier PE; Lucotte EA; Domenighetti C; Law MH; Iles MM; Brown K; Amos C; McKay JD; Hung RJ; Karimi M; Bacq-Daian D; Boland-Augé A; Olaso R; Deleuze JF; Lesueur F; Ostroumova E; Kesminiene A; de Vathaire F; Guénel P; ; Sreelatha AAK; Schulte C; Grover S; May P; Bobbili DR; Radivojkov-Blagojevic M; Lichtner P; Singleton AB; Hernandez DG; Edsall C; Mellick GD; Zimprich A; Pirker W; Rogaeva E; Lang AE; Koks S; Taba P; Lesage S; Brice A; Corvol JC; Chartier-Harlin MC; Mutez E; Brockmann K; Deutschländer AB; Hadjigeorgiou GM; Dardiotis E; Stefanis L; Simitsi AM; Valente EM; Petrucci S; Straniero L; Zecchinelli A; Pezzoli G; Brighina L; Ferrarese C; Annesi G; Quattrone A; Gagliardi M; Matsuo H; Nakayama A; Hattori N; Nishioka K; Chung SJ; Kim YJ; Kolber P; van de Warrenburg BPC; Bloem BR; Aasly J; Toft M; Pihlstrøm L; Guedes LC; Ferreira JJ; Bardien S; Carr J; Tolosa E; Ezquerra M; Pastor P; Diez-Fairen M; Wirdefeldt K; Pedersen N; Ran C; Belin AC; Puschmann A; Rödström EY; Clarke CE; Morrison KE; Tan M; Krainc D; Burbulla LF; Farrer MJ; Kruger R; Gasser T; Sharma M; ; Truong T; Elbaz A
    Mov Disord; 2023 Apr; 38(4):604-615. PubMed ID: 36788297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double Trouble: Association of Malignant Melanoma with Sporadic and Genetic Forms of Parkinson's Disease and Asymptomatic Carriers of Related Genes: A Brief Report.
    Koros C; Simitsi AM; Bougea A; Papagiannakis N; Antonelou R; Pachi I; Angelopoulou E; Prentakis A; Zachou A; Chrysovitsanou C; Beratis I; Fragkiadaki S; Kontaxopoulou D; Eftymiopoulou E; Stanitsa E; Potagas C; Papageorgiou SG; Karavasilis E; Velonakis G; Prassopoulos V; Geronicola-Trapali X; Stefanis L
    Medicina (Kaunas); 2023 Jul; 59(8):. PubMed ID: 37629650
    [No Abstract]   [Full Text] [Related]  

  • 4. No Evidence for a Causal Relationship Between Cancers and Parkinson's Disease.
    Senkevich K; Bandres-Ciga S; Yu E; Liyanage UE; ; Noyce AJ; Gan-Or Z
    J Parkinsons Dis; 2021; 11(2):801-809. PubMed ID: 33646179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-proteasome system and Parkinson's diseases.
    Betarbet R; Sherer TB; Greenamyre JT
    Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological proteins in Parkinson's disease: focus on the proteasome.
    Snyder H; Wolozin B
    J Mol Neurosci; 2004; 24(3):425-42. PubMed ID: 15655264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetics and environmental factors of Parkinson disease].
    Broussolle E; Thobois S
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S11-23. PubMed ID: 12690660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of Parkinson's disease.
    Nussbaum RL; Polymeropoulos MH
    Hum Mol Genet; 1997; 6(10):1687-91. PubMed ID: 9300660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hair color, family history of melanoma, and the risk of Parkinson's disease: An analysis update.
    Flores-Torres MH; Bjornevik K; Zhang X; Gao X; Hung AY; Schwarzschild MA; Chen X; Ascherio A
    Parkinsonism Relat Disord; 2024 Feb; 119():105965. PubMed ID: 38142631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease.
    Hattori N; Shimura H; Kubo S; Wang M; Shimizu N; Tanaka K; Mizuno Y
    J Neural Transm Suppl; 2000; (60):101-16. PubMed ID: 11205133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes.
    Lim KL; Lim TM
    IUBMB Life; 2003 Jun; 55(6):315-22. PubMed ID: 12938733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating melatonin levels: possible link between Parkinson's disease and cancer risk?
    Schernhammer E; Chen H; Ritz B
    Cancer Causes Control; 2006 May; 17(4):577-82. PubMed ID: 16596313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease.
    Dong J; Gao J; Nalls M; Gao X; Huang X; Han J; Singleton AB; Chen H;
    Neurobiol Aging; 2014 Jun; 35(6):1512.e5-1512.e10. PubMed ID: 24439955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease: one biochemical pathway to fit all genes?
    Krüger R; Eberhardt O; Riess O; Schulz JB
    Trends Mol Med; 2002 May; 8(5):236-40. PubMed ID: 12067634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease.
    Videnovic A; Noble C; Reid KJ; Peng J; Turek FW; Marconi A; Rademaker AW; Simuni T; Zadikoff C; Zee PC
    JAMA Neurol; 2014 Apr; 71(4):463-9. PubMed ID: 24566763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature.
    Zanetti R; Loria D; Rosso S
    Melanoma Res; 2006 Jun; 16(3):201-6. PubMed ID: 16718266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of Parkinson's disease genetics.
    Lorincz MT
    Semin Neurol; 2006 Nov; 26(5):492-8. PubMed ID: 17048150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex interactions in Parkinson's disease: a two-phased approach.
    Maraganore DM; de Andrade M; Lesnick TG; Farrer MJ; Bower JH; Hardy JA; Rocca WA
    Mov Disord; 2003 Jun; 18(6):631-6. PubMed ID: 12784265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of Parkinson's disease.
    Gasser T
    J Neurol; 2001 Oct; 248(10):833-40. PubMed ID: 11697518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.